Molecular cloning and expression analysis of five novel genes in chromosome 1p36

Genomics

Volumn 50, Issue 2, 1998, Pages 187-198

  Onyango, Patrick ^a,b   Lubyova, Barbora ^a,b   Gardellin, Paola ^a   Kurzbauer, Robert ^a   Weith, Andreas ^a,c  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CHROMOSOME 1P; GENE DELETION; GENE LOCATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HUMAN; KARYOTYPE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TELOMERE; TUMOR SUPPRESSOR GENE;

EID: 0032103490     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.5186     Document Type: Article

References (67)

1. Aldred P., Fu P., Barret G., Penschow J. D., Wright R. D., Coghlan J. P., Fernley T. Human secreted carbonic anhydrase: cDNA cloning, nucleotide sequence, and hybridization histochemistry. Biochemistry. 30:1991;569-575.
2. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
3. Ariyama T., Hasegawa K., Inazawa J., Mizuno K., Ogimoto M., Katagiri T., Yakura H. Assignment of the human tyrosine phosphatase, receptor-type, zeta (PTPRZ) gene to chromosome band 7q31.3. Cytogenet. Cell Genet. 70:1995;52-54.
4. Bader S. A., Fasching C., Brodeur G. M., Stanbridge E. J. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ. 2:1991;245-255.
5. Barnas C. M., Onyango P., Ellmeier W., Lengauer C., Kleiner E., Henn T., Brunner C., Stepleton P., Weith A. Determination and regional assignment of grouped sets of microclones in chromosome 1pter-p35. Genomics. 29:1995;607-615.
6. Biedler J. L., Helson L., Spengler G. A. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cell lines in continuous culture. Cancer Res. 33:1983;2643-2652.
7. Brodeur G., Sekhon G., Goldstein M. Chromosomal aberrations in human neuroblastoma. Cancer. 40:1977;2256-2263.
8. Brown E. J., Albers M. W., Shin T. B., Ichikawa K., Keith C. T., Lane W. S., Schreiber S. L. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 369:1994;756-758.
9. Brown E. J., Beal P. A., Keith C. T., Chen J., Shin T. B., Schreiber S. L. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature. 377:1995;441-446.
10. Brown E. J., Schreiber L. S. A signaling pathway to translational control. Cell. 86:1996;517-520.
11. Cafferkey R., Young P. R., MacLaughin M. M., Bergsma D. J., Koltin Y., Sathe G. M., Faucette L., Eg W. K., Johnson R. K., Livi G. P. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol. Cell Biol. 13:1993;6012-6023.
12. Casciano I., Marchi J. V. M., Muresu R., Volpi E. V., Rozzo C., Opdenakker G., Romani M. Molecular and genetic studies on the region of translocation and duplication in the neuroblastoma cell line NGP at the 1p36.13-p36.32 chromosomal site. Oncogene. 12:1996;2101-2108.
13. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
14. Church D. M., Stotler C. J., Rutter J. L., Murrell J. R., Trofatter J. A., Buckler A. J. Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nature Genet. 6:1994;98-105.
15. Collins F. S. Positional cloning moves from perditional to traditional. Nature Genet. 9:1995;347-350.
16. Diederich M., El yaagoubi M., Gerardin P., Wellman M., Siest G. Characterization and regulatory effect of gamma-glutamyltransferase messenger RNA untranslated regions in human leukemia. Leukemia. 9:1995;1332-1337.
17. Dracopoli N. C., Harnet P., Bale S. J., Stanger B. Z., Tucher M. A., Housman D. E., Kefford R. F. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc. Natl. Acad. Sci. USA. 86:1989;4614-4618.
18. Durkop H., Latza U., Hummel M., Eitelbach F., Seed B., Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell. 68:1992;421-427.
19. Ellmeier W., Aguzzi A., Kleiner E., Kurzbauer R., Weith A. Mutually exclusive expression of a helix-loop-helix gene and N-myc in human neuroblastoma and in normal development. EMBO J. 11:1992;2563-2571.
20. Enomoto H., Ozaki T., Takahashi E., Nomura N., Tabata S., Takahashi H., Ohnuma N., Tanabe M., Iwai J., Yoshida H., Matsunaga T., Sakiyama S. Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus. Oncogene. 9:1994;2785-2791.
21. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA fragments to high specific activity. Anal. Biochem. 137:1983;266-267.
22. Fonatsch C., Latza U., Durkop H., Rieder H., Stein H. Assignment of the human CD30 (Ki-1) gene to 1p36. Genomics. 14:1992;825-826.
23. Fong C. T., Dracopoli N. C., White P. S., Merril P. G. T, Griffith R. C., Housman D. E., Brodeur G. M. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastoma: Correlation with N-myc amplification. Proc. Natl. Acad. Sci. USA. 86:1989;3735-3757.
24. Francis F., Zehetner G., Hoglund M., Lehrach L. Construction and preliminary analysis of the ICRF human P1 library. Genet. Anal. Tech Appl. 11:1994;148-157.
25. Goldstein A. M., Dracopoli N. C., Ho E. C., Fraser M. C., Kearns K. S., Bale S. J., McBride O. W., Clark W. J. Jr., Tucker M. A. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM7DN) on chromosome 1p, and evidence for genetic heterogeneity. Am. J. Hum. Genet. 52:1993;537-550.
26. Gosden C. M., Davidson C., Robertson M. Human cytogenetics: A Practical Approach. 1992;. p. 31-54.
27. Giallongo A., Feo S., Moore R., Croce C. M., Showe L. C. Molecular cloning and nucleotide sequence of a full-length cDNA for human α enolase. Proc. Natl. Acad. Sci. USA. 83:1986;6741-6745.
28. Hartwell L. H., Kastan M. B. Cell cycle control and cancer. Science. 266:1994;1821-1828.
29. Heim S., Mitelman F. Cancer Cytogenetics. 1995;Wiley-Liss, New York. p. 443.
30. Helson L., Helson C. Human neuroblastoma cells and 13cis. J. Neurol. Oncol. 3:1985;39-41.
31. Imamoto A., Soriano P., Stein P. L. Genetics of signal transduction: Tales from the mouse. Curr. Opin. Genet. Dev. 4:1994;40-46.
32. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A., Minty A., Chalon P., Lelias J. M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90:1997;809-819.
33. Kamb A. Cell-cycle regulators and cancer. Trends Genet. 11:1995;136-140.
34. Keith C. T., Schreiber L. S. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science. 270:1995;50-51.
35. Khosla S., Patel V. M., Hay I. D., Schaid D. J., Grant C. S., van Heerden J. A., Thibodeau S. N. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J. Clin. Invest. 87:1991;1691-1699.
36. Kozak M. Point mutation defines a sequence flanking the AUG initiator codon that modulates translation by eucaryotic ribosomes. Cell. 44:1986;283-292.
37. Kunz J., Henriquez R., Schneider U., Deuter-Reinhard M., Movva N. R., Hall M. N. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinosital kinase homolog required for G1 progression. Cell. 73:1993;585-596.
38. Kuroki T., Fujiwara T., Tsuchiya E., Nakamori S., Imaoka S., Kanematsu T., Nakamura Y. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: Loss of chromosome arm 1 occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes Cancer. 13:1995;163-167.
39. Lahti J. M., Valentine M., Xiang J., Jones B., Amann J., Grenet J., Richmond G., Look A. T., Kidd V. J. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nature Genet. 7:1994;370-375.
40. Lengauer C., Henn T., Onyango P., Francis F., Lehrach H., Weith A. Large-scale isolation of human 1p36-specific P1 clones and their use for fluorescence in situ hybridization. Genet. Anal. Tech. Appl. 11:1994;140-147.
41. Martinsson T., Sjöberg R-M., Hedborg F., Koger P. Deletion of chromosome 1p loci and microsatellite instability in neuroblastoma analysed with short-tandem repeat polymorphisms. Cancer Res. 55:1995;5681-5686.
42. Martinsson T., Weith A., Cziepluch C., Schwab M. Chromosome 1 deletion in human neuroblastomas: Generation and fine mapping of microclones from the distal 1p region. Genes Chromosomes Cancer. 1:1989;67-78.
43. Moore P. A., Rosen C. A., Carter K. C. Assignment of the human FKBP12-rapamycin-associated protein (FRAP) gene to chromosome 1p36 by fluorescencein situ. Genomics. 33:1996;331-332.
44. Munn K. E., Walker R. A., Varley J. M. Frequent alterations of chromosome 1 in ductal carcinoma. Oncogene. 10:1995;1653-1657.
45. Nagai H., Negrini M., Carter S. L., Gillum D. R., Rosenberg A. L., Schwartz G. F., Croce C. M. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res. 55:1995;1752-1757.
46. Nizetic D., Monard S., Young B., Cotter F., Zehetner G., Lehrach H. Construction of cosmid libraries from flow-sorted human chromosome 1, 6, ,11, 13 and 18 for reference library resources. Mamm. Genome. 5:1994;801-802.
47. Kip1. Nature. 372:1994;570-573.
48. Oikawa S., Imai M., Ueno A., Tanaka S., Noguchi T., Nakazato H., Kangawa K., Fukuda A., Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for the human atrial natriuretic polypeptide. Nature. 309:1984;724-726.
49. Parimoo S., Patanjali R. S., Shukla H., Chaplin D. D., Weissman S. cDNA\tab selection: Efficient PCR approach for the selection of cDNAs encoded in large chromosomal DNA fragments. Proc. Natl. Acad. Sci. USA. 88:1991;9623-9627.
50. Povey S., Morton N. E., Sherman S. L. Report of the Committee on the Genetic Constitution of Chromosome 1 and 2. Cytogenet. Cell Genet. 40:1985;67-106.
51. Praml C., Finke L. H., Herfarth C., Schlag P., Schwab M., Amler L. C. Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene. 11:1995;1357-1362.
52. Ray R. Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Cell Growth Differ. 9:1995;1089-1096.
53. Ray R., Miller D. M. Cloning and characterisation of a human c-myc promoter-binding protein. Mol. Cell. Biol. 11:1991;2154-2161.
54. Ray R. B., Steele R., Seftor E., Hendrix M. Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res. 55:1995;3747-3751.
55. Rodrigues A. G., Park M. Oncogenic activation of tyrosine kinases. Curr. Opin. Genet. Dev. 4:1994;15-24.
56. Sabatini D. M., Erdjument-Bromage H., Lui M., Tempst P., Snyder S. H. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell. 78:1994;35-36.
57. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
58. Schwab M., Praml C., Amler L. C. Genomic instability in 1p and the human malignancies. Genes Chomosomes Cancer. 16:1996;211-229.
59. Simon D., Knowles B. B., Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene. 6:1991;765-770.
60. cdc2L1. Int. J. Oncol. 8:1996;1137-1142.
61. Sutherland G. R., Baker E., Fernandez K. E. W., Callen D. F., Aldred P., Coghlan J. P., Wright R. D., Fernley R. T. The gene for human carbonic anhydrase VI (CA6) is on the tip of the short arm of chromosome 1. Cytogenet. Cell Genet. 50:1989;149-150.
62. Takeda O., Homma C., Maseki N., Sakurai M., Kanda N., Schwab M., Nakamura Y., Kaneko Y. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer. 10:1994;30-39.
63. Tanaka K., Yanoshita R., Konishi M., Oshimura M., Maeda Y., Mori T., Miyaki M. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal human chromosome 1p36 region. Oncogene. 8:1993;2253-2258.
64. Weith A., Martinsson T., Cziepluch C., Brüderlein S., Amler L. C., Berthold F., Schwab M. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer. 1:1989;159-166.
65. White P. S., Maris J. M., Beltinger C., Sulman E., Marshall H. N., Fujimori M., Kaufman B. A., Biegel J. A., Allen C., Hilliard C., Valentine M. B., Look A. T., Enomoto H., Sakiyama S., Brodeur G. M. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc. Natl. Acad. Sci. USA. 92:1995;5520-5524.
66. Yang K. P., Nguyen C. V., Castillo S. G., Samaan N. A. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIa. Anticancer Res. 10:1990;527-534.
67. Yang-Feng T. L., Floyed-Smith G., Nemer M., Drouin J., Francke U. The pronatriodilatin gene is located on the distal short arm of human chromosome 1 and on mouse chromosome 4. Am. J. Hum. Genet. 37:1985;1117-1128.